| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |